04.03.2013 19:35 Uhr, Quelle: Wallstreet online

Regulatory Update -- Stiefel, a GSK company announces a new, alternate, fixed-dose combination of Duac® (clindamycin 1% and benzoyl peroxide 3%) gains positive recommendation for approval in Europe

RESEARCH TRIANGLE PARK, North Carolina, March 4, 2013 /PRNewswire/ Stiefel, a GSK company, announced today that it has received positive recommendation by MHRA (Medicine and Healthcare products Regulatory Agency, UK) for the approval of a …

Weiterlesen bei Wallstreet online